 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Thomas Andrew Minetree, M.D. is a pioneer of free-standing cancer centers. He is a thrice board-certified physician in radiation oncology, diagnostic radiology, and nuclear medicine.
In 1976, with the vision of bringing big-city cancer care to small communities, Dr. Minetree founded Bethesda Cancer Centers, becoming the first private individual in the United States to open a free-standing radiation therapy cancer center. During his twenty-plus year leadership of Bethesda Cancer Treatment Centers, Dr. Minetree opened fifteen cancer centers throughout the southern and midwestern United States, providing thousands of patients with quality cancer care that was previously unavailable in their hometowns. Bethesda Cancer Centers are now owned and operated by Sonix Medical Resources, Inc., a New York Corporation.
Dr. Minetree is now retired from the practice of medicine. He and his wife, Virginia, currently enjoy spending time at their mountain ranch outside of Aspen, Colorado. In 2008, Dr. Minetree was honored by the American Cancer Society for his contribution to oncology.
A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.
Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.
Spartanburg Regional Healthcare System(SRHS) is one of South Carolina's largest healthcare systems. SRHS draws patients primarily from the areas of Spartanburg, Cherokee, Union and Greenville counties, located in the Piedmont region of South Carolina, and Rutherford and Polk counties, located in western North Carolina. Spartanburg General Hospital was organized under the authority of the South Carolina General Assembly in 1917, and officially became the Spartanburg Regional Health Services District, Inc., a political subdivision of the State of South Carolina, by charter granted by the secretary of state of South Carolina on May 1, 1995.
Stephen Michael Hahn is an American physician who served as the Commissioner of Food and Drugs from 2019 to 2021. Before becoming Commissioner, he was an oncologist serving as Chief Medical Executive of the MD Anderson Cancer Center.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center located in Baltimore, Maryland.
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is called an Oncologist.
Brian Patrick Monahan is the Attending Physician of the United States Congress and the United States Supreme Court and holds the rank of rear admiral in the United States Navy. Monahan was selected by the leadership of the Congress and nominated to the position and rank by United States President Barack Obama in January 2009. He previously served as the director of hematology and medical oncology at the National Naval Medical Center. He is a Master of The American College of Physicians and a Member of the Academy of Medicine.
The UPMC Hillman Cancer Center (Hillman), previously titled the University of Pittsburgh Cancer Institute (UPCI), is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located in the Hillman Cancer Center in the Shadyside neighborhood of Pittsburgh, Pennsylvania, United States, adjacent to UPMC Shadyside. The only NCI-designated cancer center in Western Pennsylvania, Hillman is composed of collaborative academic and research efforts between the University of Pittsburgh, the University of Pittsburgh Medical Center (UPMC), and Carnegie Mellon University. Hillman provides clinical cancer care to some 74,000 patients treated at its facilities at both the Hillman Cancer Center location in the Shadyside neighborhood of Pittsburgh and at UPMC-affiliated sites throughout Pennsylvania, New York, Ohio, and overseas locations. Founded in 1984, Hillman became the youngest cancer center in history to achieve NCI-designation. As of 2007, Hillman had received nearly $200 million in funding from the National Cancer Institute, which ranks it as one of the top ten cancer research institutes.
Dr. Dattatreyudu Nori is a noted Indian radiation oncologist. He was once named one of the top doctors in America for the treatment of cancers in women by the women's magazine Ladies' Home Journal.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
Professor Minesh P Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.
David Henry Gorski is an American surgical oncologist, professor of surgery at Wayne State University School of Medicine, and a surgical oncologist at the Barbara Ann Karmanos Cancer Institute, specializing in breast cancer surgery. He is an outspoken skeptic, and a critic of alternative medicine and the anti-vaccination movement. He is the author of the blog Respectful Insolence, and the managing editor of the website Science-Based Medicine.
Julian C. Josey Jr. is a radiation oncologist at the Gibbs Cancer Center & Research Institute in Spartanburg, South Carolina. A native of Spartanburg, he has been a leader in the diagnosis and treatment of cancer for more than 40 years.
Ronald B. Herberman was a physician, immunologist, oncologist, researcher, and professor of medicine and pathology who founded the University of Pittsburgh Cancer Institute (UPCI), a National Cancer Institute (NCI)-designated Comprehensive Care Center in 1984. He helped discover natural killer cells capable of killing cancer. He became well known outside the medical community in 2008 for his public warning about the potential health impacts of mobile telephones and recommending a reduction in their use.
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Joaquín Gómez Mira is a scientist and physician specialized in radiation oncology. Born and raised in Spain, he completed his studies and developed his career in the United States, where he moved in 1967. He is a member of the American Society of Clinical Oncology, and a Fellow and appointed councilor of the American College of Radiology. His work, achievements and lectures in the field of radiation oncology are held in high regard.
Walter "Wally" J. Curran, Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer. He is the global chief medical officer of GenesisCare, a provider of cancer and cardiovascular care that serves communities in 440 locations across the world.
Catherine Naliaka Nyongesa Watta, is a Kenyan physician and radiation oncologist, who is the founder, owner and chief executive of Texas Cancer Centre, in Nairobi, the capital and largest city in the country.
Edith Peterson Mitchell is a retired Brigadier general of the United States Air Force and an oncologist. She is clinical professor of medicine and medical oncology at Thomas Jefferson University. In 2015, she became the president of the National Medical Association.
Reshma Jagsi is an American Radiation oncologist. She is the Newman Family Professor and Deputy Chair in the Department of Radiation Oncology and Director of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan. Overall, she is the author of over 350 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest: breast cancer, bioethics, and gender equity, with the support of grants from the National Institutes of Health (NIH), the Doris Duke Charitable Foundation, and the Susan G. Komen Foundation, for which she serves as a Senior Scholar.
